Integrated Workflows Refeyn has launched an integrated analytical workflow with Bio-Techne and R&D Systems to enable simultaneous analysis of charge, size, and aggregation for bispecific antibodies and biosimilars. This creates a compelling co selling opportunity with partner ecosystems and a strong value proposition for biotherapeutic teams seeking faster, single molecule level insights. Target stakeholders include protein characterization leads, process development scientists, and procurement managers in biopharma and CROs.

Portfolio Expansion The MyMass instrument and the StreamlineMP automated software platform expand Refeyn’s product and service footprint beyond hardware to streamlined data capture and automated analysis. This opens upsell opportunities for labs in structural biology and quality assessment, and provides a pathway to bundled offerings that combine hardware with software, services, and support.

Global Credibility Refeyn’s global installations, broad citation base, and use in high profile research establish credibility that helps win business with leading biotech and pharma customers. This enables premium positioning, easier multi site deployments, and faster procurement across large research organizations and academic networks.

European Growth Located in Oxford, Refeyn sits in a major European biotech hub and is well positioned to deepen engagement with European universities and biotech companies. Partnerships with established distributors and corporate partners can extend geographic reach and support adoption in adjacent markets.

Strategic Partnerships The company’s announced funding and revenue potential signal scale readiness to support partnerships, co development, and extended service models. This provides a solid basis for joint ventures, distribution deals, and bundled offerings that pair mass photometry hardware with workflow software and integrated analytical capabilities.